Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia.
Age is a dominant predictor of outcome in acute myeloid leukemia (AML). However, it is not clear to which extent comorbidities contribute to this effect. The objective of this study was to determine the impact of pretreatment comorbidities on survival of AML patients. In a single-center retrospectiv...
Main Authors: | Maxi Wass, Friederike Hitz, Judith Schaffrath, Carsten Müller-Tidow, Lutz P Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5061362?pdf=render |
Similar Items
-
The value of comorbidity for stratification of an acute myeloid leukemias treatment in adults
by: Надежда Валерьевна Горяинова
Published: (2015-06-01) -
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
by: Susanne Hofmann, et al.
Published: (2019-02-01) -
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
by: Michele Pohlen, et al.
Published: (2016-01-01) -
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
by: Michele Pohlen, et al.
Published: (2018-01-01) -
Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.
by: Alexander Leonardo Silva-Junior, et al.
Published: (2019-01-01)